Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.
about
The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasisExpression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinomaCXCR3 in carcinoma progressionStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesisAkt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cellsCXCR4 regulates the early extravasation of metastatic tumor cells in vivoReassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2.Roles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity.CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomasCCR6 is a prognostic marker for overall survival in patients with colorectal cancer, and its overexpression enhances metastasis in vivo.Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.Nf-kappa B, chemokine gene transcription and tumour growthThe therapeutic potential of CXCR4 antagonists in the treatment of HIV.Proteomic analysis of proton beam irradiated human melanoma cellsIntracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation.Promoters with cancer cell-specific activity for melanoma gene therapy.CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factorsPAX3 and FOXD3 Promote CXCR4 Expression in MelanomaRole of chemokines in tumor growth.The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.NF-kappaB activation in melanoma.Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.CXCL10/CXCR3 overexpression as a biomarker of poor prognosis in patients with stage II colorectal cancer.Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process.Pathophysiology of tumor neovascularization.Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cellsG-protein-coupled receptors and melanomaOverexpression of E-cadherin on melanoma cells inhibits chemokine-promoted invasion involving p190RhoGAP/p120ctn-dependent inactivation of RhoA.Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.Exploratory studies on development of the chemokine receptor CXCR4 antagonists toward downsizing.Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs.Chemokines: key players in cancer progression and metastasis.A future perspective on the development of chemokine receptor CXCR4 antagonists.CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.Chemokines in the melanoma metastasis biomarkers portrait.Targeting Melanoma with Cancer-Killing Viruses.
P2860
Q21093318-2D1EB432-D746-4F90-9EC7-B094FB5E5E7EQ24803472-A46B3CE8-62A7-40DA-B7A1-A66DA5BE7E01Q26826928-7430B257-42C5-4541-8A5E-5BFB9DD517EAQ28260997-C67C5D1D-7FAA-49DD-985C-FFF53AECD1BEQ28271040-F5BE510A-1E2E-4F4D-879F-54E321E74C92Q30488263-DE5CA70B-C6DF-40CE-9FBC-C35AB1EAA9C3Q33396653-31DE0553-2B8E-450D-8521-6C995851BF87Q33816250-E7403CD5-920E-47FB-91A4-CAF3DD296E0FQ33816432-F9C140E6-496E-4374-922D-98C318FC396DQ33825513-2D871D09-A573-4EDF-877D-51D774C8DECFQ33964919-6E34DD32-0B05-402E-9131-1A2B9D674AB6Q34496096-20B99F54-2225-4615-B2ED-FC79C30B75D9Q34613650-247C941F-2FAB-488A-887D-35CE6C60448AQ34628723-EF56ABC2-08AB-4866-8008-1C42C24483C4Q34810265-11BF6DEB-7762-474F-86A9-77505E31A468Q35056053-2ED81753-64DA-4F85-BD8E-31AB12267DFFQ35083440-D4CEB980-FF2B-4366-A963-B7CD9C523FF0Q35100014-2A4D5810-B2E4-4A61-A4BD-784601477B18Q35944371-4EF3C892-74D2-4460-927A-EF15E02A05A5Q35954365-F44E5CBE-B9A5-455D-A1F0-C691B09DCDCDQ36065213-83152916-A583-44A5-A36F-543129544422Q36120825-F9D7C964-EF95-480F-A781-AF757E895980Q36318564-6CB92535-E70C-4A9D-B47D-C88A5C159FB4Q36416479-1D1E7A3F-FD4F-4F19-B0AB-0553A17D7DEBQ36432030-058A6689-4954-484F-A6F9-E727653E864AQ36502337-CD6D599A-4AAC-4FA0-AED9-4ADE83AC0B51Q36617032-1B607573-4C06-4BF7-80CC-6998B208F8A5Q36742274-E59714E3-01BD-405F-8912-3BEC27FBB27CQ37149868-C2A2721F-5CFE-4FAC-A0E6-AC50B8483C82Q37200841-24F43896-AF77-40A5-98A7-E72C672041CCQ37200887-9826BAD3-5DDE-4327-89C8-0676867BE841Q37351199-7DC0DE80-9FF9-40FC-8679-E6B2D7944A8CQ37352728-DB795E7B-9F2F-40C0-B66E-A41B4594C928Q37396826-F671716A-CB06-4EFD-924F-D52759A2EDFFQ37409509-076660B7-451A-4669-A89C-AA9DEEFE7B04Q37881763-8F10BB42-884E-48E2-8C5F-8B9E897BADA2Q38089173-F7309A5E-C7C2-425B-B59D-29E6A3B5DABFQ38303390-2E78AD89-E7F1-4516-AE43-903D61443876Q38403945-B3C45B6E-189A-45F1-A651-41AEAFE152B8Q38676416-86F3E0FA-8C69-4026-AE5E-C738A73FAF46
P2860
Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.
@en
type
label
Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.
@en
prefLabel
Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.
@en
P2093
P2860
P356
P1476
Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells.
@en
P2093
Bartolome RA
Robledo MM
Rodríguez-Frade JM
Sánchez-Mateos P
van Muijen GN
P2860
P304
45098-45105
P356
10.1074/JBC.M106912200
P407
P577
2001-09-24T00:00:00Z